Combination atezolizumab, bevacizumab, pemetrexed and carboplatin for metastatic EGFR mutated NSCLC after TKI failure
Tai‐Chung Lam, K. C. TSANG, Cheuk‐Wai Choi, Victor Lee, Ka On Lam, Chi‐Leung Chiang, T.H. So, Wing‐Lok Chan, S.F. Nyaw, F. Lim, Joseph Lau, Jeannie Chik, Feng‐Ming Kong, A.W. Lee
Topics & Concepts
MedicineAtezolizumabPemetrexedInternal medicineCarboplatinOsimertinibRegimenLung cancerBevacizumabOncologyAdverse effectChemotherapyCancerEpidermal growth factor receptorErlotinibImmunotherapyNivolumabCisplatinLung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersRadiomics and Machine Learning in Medical Imaging